Nisa Investment Advisors
ALDR

Nisa Investment Advisors’s Alder Biopharmaceuticals ALDR Stock Holding History

Nisa Investment Advisors’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-700
Closed -$13K – 2076
2019
Q3 		$13K Hold
700
– – ﹤0.01% 1730
2019
Q2 		$8K Hold
700
– – ﹤0.01% 1829
2019
Q1 		$10K Hold
700
– – ﹤0.01% 1773
2018
Q4 		$7K Hold
700
– – ﹤0.01% 1748
2018
Q3 		$12K Hold
700
– – ﹤0.01% 1686
2018
Q2 		$11K Buy
700
+380
+119% +$5.77K ﹤0.01% 1723
2018
Q1 		$4K Sell
320
-550
-63% -$7.96K ﹤0.01% 1831
2017
Q4 		$10K Buy
870
+600
+222% +$6.7K ﹤0.01% 1756
2017
Q3 		$3K Sell
270
-600
-69% -$6.26K ﹤0.01% 1837
2017
Q2 		$10K Buy
870
+550
+172% +$10.2K ﹤0.01% 1738
2017
Q1 		$7K Sell
320
-280
-47% -$6.2K ﹤0.01% 1777
2016
Q4 		$12K Buy
+600
New +$15.6K ﹤0.01% 1780

Nisa Investment Advisors's ALDR Position: Q4 2019 in Review

Nisa Investment Advisors sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 700 shares — an estimated $13K sold.

Nisa Investment Advisors first reported a position in ALDR in Q4 2016 and held it in 12 quarters. The position peaked at $13K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Nisa Investment Advisors reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Nisa Investment Advisors sold 700 Alder Biopharmaceuticals shares in Q4 2019, an estimated $13K.
  • Nisa Investment Advisors first reported a position in Alder Biopharmaceuticals in Q4 2016 and held it in 12 quarters.
  • Nisa Investment Advisors's Alder Biopharmaceuticals position peaked at $13K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Nisa Investment Advisors's 13F filing for Q4 2019, filed 17 Jan 2020.